Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
South Danish Hypertension and Diabetes Study
2009-017033-22Phase 4Completed
- Sponsor
- University Hospital Odense
- Start
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in hypertension (HTN) and type 2 diabetes mellitus (T2DM) comparing Spironolactone add-on with Placebo add-on (2 arms). Primary endpoints: Change in blood pressure and Proportion achieving target blood pressure. Started Jan 2010; status: completed.
02
Drugs
spironolactone
03
Conditions
hypertension (HTN)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2009-017033-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017033-22.